Clinical trial
Use of Pyridostigmine for Constipation in Diabetics
NCT00276406 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00276406 |
|---|---|
| Title | Use of Pyridostigmine for Constipation in Diabetics |
| Official title | Pyridostigmine in Diabetics With Constipation: Randomized, Placebo-controlled, Double-blind Trial |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Constipation, Diabetes Mellitus, Colonic Transit, Gastric Emptying |
| Intervention type | Drug |
| Interventions | Pyridostigmine, Placebo |
| Enrollment | 30 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Jan 13, 2006 |
| Last update posted | Nov 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: